MedTrace Logo

Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition

NCT00956917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2009-08-11

No results posted yet for this study

Summary

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition.

Conditions

  • Body Composition Measurement

Interventions

DEVICE

Akern USA EFG

Impedance measurement device

DEVICE

RJL Impedance analyzer

Impedance analyzer

Sponsors & Collaborators

  • Akern USA LLC

    lead INDUSTRY

Principal Investigators

  • Luca Gatteschi, MD

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00956917 on ClinicalTrials.gov